Press Releases

Elizabeth Clark Moore, M.S.

Ms. Moore has served as our Executive Vice President of Regulatory Affairs since May 2015. She has over thirty years of experience in strategic regulatory registration and product development; management of FDA and global health authority interactions; and completion of regulatory and other due diligence for acquisition targets. Ms. Moore started her career at the National Institutes of Health (“NIH”), having served eight years with posts at both the National Institute of Allergy and Infectious Diseases and the National Cancer Institute. Her industry experience spans traditional pharmaceutical companies as well as biotech start-ups. Following her tenure at the NIH, Ms. Moore joined Agouron Pharmaceuticals as Director, Regulatory Affairs for Oncology Development. Subsequent to the Pfizer-Warner Lambert acquisition of Agouron, Ms. Moore was appointed Regulatory Affairs Site Head (Senior Director) of Pfizer Global R&D in La Jolla, CA. For the past fifteen years, Ms. Moore has directed global regulatory affairs strategy and operations for both public and private companies, holding senior-level positions at Coronado Biosciences (now Fortress), Paramount BioSciences, Tracon Pharmaceuticals, Salmedix (acquired by Cephalon), and most recently, Fate Therapeutics. Ms. Moore received her B.S. in Pharmacy from the University of Georgia and M.S. in Administrative Science from the Johns Hopkins University.